Understanding liver disease linked to obesity and exploring new treatments
Official title: MASH Pathogenesis and Therapeutic Approaches
Funded at Keystone Symposia · NIH-11071843 · Data updated 2026-11-12
This study is all about a conference where experts will talk about how obesity affects liver disease, and it aims to find better treatments, like surgery and medications, that could help patients with these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Keystone Symposia NIH-funded |
| Lab location | 1 site (Silverthorne, United States) |
| Project start | January 8, 2025 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $16,900 |
| NIH project number | 1R13DK142553-01 |
| Project ID | NIH-11071843 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals affected by obesity and related liver conditions, such as MASLD or MASH.
✕Less likely to help
Patients with liver diseases not associated with obesity or metabolic dysfunction may not benefit from this research.
What this research studies
This research focuses on a conference that will bring together experts to discuss the connections between obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). The conference aims to advance knowledge on the mechanisms driving liver disease and explore new therapeutic approaches, including bariatric surgery and medications. Patients can benefit from the insights gained at this conference, as it may lead to improved treatment options for liver diseases associated with obesity. The discussions will also address the increasing prevalence of liver disease and the urgent need for effective medical treatments.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies for patients suffering from liver diseases related to obesity.
How similar studies have gone: Previous conferences and research have successfully advanced understanding and treatment of obesity-related diseases, indicating a strong potential for impactful outcomes from this conference.
Where this research is happening
-
Keystone Symposia
Silverthorne, United States Active
Researchers
- Principal investigator: Sheppard, Terry L. — Keystone Symposia
- Study coordinator: Sheppard, Terry L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.